Literature DB >> 7536332

The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes.

T Haaf1.   

Abstract

5-Azacytidine (5-aza-C) analogs demonstrate a remarkable ability to induce heritable changes in gene and phenotypic expression. These cellular processes are associated with the demethylation of specific DNA sequences. On the other hand, 5-aza-C analogs have dramatic effects on chromosomes, leading to decondensation of chromatin structure, chromosomal instability and an advance in replication timing. Condensation inhibition of genetically inactive chromatin occurs when the DNA is still hemimethylated or fully methylated. In cell cultures prolonged for several replication cycles, chromosomal rearrangements and instability affect the 5-aza-C-sensitive regions. Moreover, the normally late-replicating inactive chromatin undergoes a transient temporal shift to an earlier DNA replication, characteristic of activatable chromatin. zThe induced alterations of chromosome structure and behavior may trigger the 5-aza-C-dependent process of cellular reprogramming. Apart from their differentiating and gene-modifying effects, 5-aza-C analogs can tumorigenically transform cells and modulate their metastatic potential. High doses of 5-aza-C analogs have cytotoxic and antineoplastic activities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536332     DOI: 10.1016/0163-7258(94)00053-6

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  49 in total

1.  Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.

Authors:  Yutaka Kondo; LanLan Shen; Jean-Pierre J Issa
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Changes in 5S rDNA chromatin organization and transcription during heterochromatin establishment in Arabidopsis.

Authors:  Olivier Mathieu; Zuzana Jasencakova; Isabelle Vaillant; Anne-Valerie Gendrel; Vincent Colot; Ingo Schubert; Sylvette Tourmente
Journal:  Plant Cell       Date:  2003-11-20       Impact factor: 11.277

3.  CpG methylation modifies the genetic stability of cloned repeat sequences.

Authors:  Kerrie Nichol; Christopher E Pearson
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

Review 4.  DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology.

Authors:  Jian Tajbakhsh
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

5.  Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus.

Authors:  Zhenbo Hu; Soledad Negrotto; Xiaorong Gu; Reda Mahfouz; Kwok Peng Ng; Quteba Ebrahem; Edward Copelan; Harinder Singh; Jaroslaw P Maciejewski; Yogen Saunthararajah
Journal:  Mol Cancer Ther       Date:  2010-05-25       Impact factor: 6.261

Review 6.  p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Authors:  Yogen Saunthararajah; Pierre Triozzi; Brian Rini; Arun Singh; Tomas Radivoyevitch; Mikkael Sekeres; Anjali Advani; Ramon Tiu; Frederic Reu; Matt Kalaycio; Ed Copelan; Eric Hsi; Alan Lichtin; Brian Bolwell
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

7.  Characterization of CpG sites that escape methylation on the inactive human X-chromosome.

Authors:  Erika L Moen; Edward Litwin; Stephen Arnovitz; Xu Zhang; Wei Zhang; M Eileen Dolan; Lucy A Godley
Journal:  Epigenetics       Date:  2015-07-15       Impact factor: 4.528

8.  Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines.

Authors:  Aaron N Nguyen; Paul W Hollenbach; Normand Richard; Antonio Luna-Moran; Helen Brady; Carla Heise; Kyle J MacBeth
Journal:  Lung Cancer (Auckl)       Date:  2010-09-09

9.  The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantation.

Authors:  Arnon Nagler; Samuel Cytron; Maya Mashevich; Avital Korenstein-Ilan; Lydia Avivi
Journal:  BMC Cancer       Date:  2010-05-24       Impact factor: 4.430

10.  Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.

Authors:  Zohar A Dotan; Aviva Dotan; Jacob Ramon; Lydia Avivi
Journal:  BMC Cancer       Date:  2008-12-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.